OQS
CBAY

Occudo Quantitative Strategies’s Cymabay Therapeutics CBAY Stock Holding History

Occudo Quantitative Strategies’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-85,812
Closed -$940K – 1391
2023
Q2 		$940K Buy
+85,812
New +$799K 0.1% 355
2022
Q1 		– Sell
-12,051
Closed -$41K – 1373
2021
Q4 		$41K Sell
12,051
-37,323
-76% -$142K ﹤0.01% 1020
2021
Q3 		$180K Sell
49,374
-34,515
-41% -$136K 0.02% 874
2021
Q2 		$366K Sell
83,889
-35,241
-30% -$156K 0.06% 523
2021
Q1 		$541K Buy
+119,130
New +$641K 0.12% 300

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Occudo Quantitative Strategies's CBAY Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Cymabay Therapeutics (CBAY) in Q3 2023, closing a stake of 85,812 shares — an estimated $940K sold.

Occudo Quantitative Strategies first reported a position in CBAY in Q1 2021 and held it in 5 quarters. The position peaked at $940K in Q2 2023. 189 funds tracked by Wall St. Rank hold CBAY as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Cymabay Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 85,812 Cymabay Therapeutics shares in Q3 2023, an estimated $940K.
  • Occudo Quantitative Strategies first reported a position in Cymabay Therapeutics in Q1 2021 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Cymabay Therapeutics position peaked at $940K in Q2 2023.
  • 189 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.